![Shunichiro Matsumoto](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Shunichiro Matsumoto
Direttore/Membro del Consiglio presso Mitobridge, Inc.
Posizioni attive di Shunichiro Matsumoto
Società | Posizione | Inizio | Fine |
---|---|---|---|
Mitobridge, Inc.
![]() Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - | - |
Potenza Therapeutics, Inc.
![]() Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - | - |
Ono Venture Investment, Inc.
![]() Ono Venture Investment, Inc. Investment ManagersFinance Ono Venture Investment Inc (Ono Venture Investment) is a venture capital arm of Ono Pharmaceutical Co Ltd. founded in 2020. The firm is headquartered in San Francisco, California. | Investitore di Private Equity | 01/11/2020 | - |
Ono Pharma USA, Inc.
![]() Ono Pharma USA, Inc. Internet Software/ServicesTechnology Services Part of Ono Pharmaceutical Co., Ltd., Ono Pharma USA, Inc. operates as a pharmaceutical platform. The company is based in Cambridge, MA. The company was founded in 1998. The CEO is Kunihiko Ito. | Investitore di Private Equity | 01/03/2022 | - |
Storia della carriera di Shunichiro Matsumoto
Precedenti posizioni note di Shunichiro Matsumoto
Società | Posizione | Inizio | Fine |
---|---|---|---|
ONO PHARMACEUTICAL CO., LTD. | Investitore di Private Equity | 01/05/2020 | 01/03/2022 |
Astellas Venture Management LLC
![]() Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | Investitore di Private Equity | 01/02/2016 | 01/03/2020 |
Astellas Pharma US, Inc.
![]() Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Investitore di Private Equity | 01/01/2007 | 01/09/2013 |
Formazione di Shunichiro Matsumoto
University of Tsukuba | Doctorate Degree |
Kyoto University | Graduate Degree |
McGill University | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Giappone | 4 |
Canada | 2 |
Posizioni
Private Equity Investor | 5 |
Director/Board Member | 2 |
Doctorate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 4 |
Finance | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ONO PHARMACEUTICAL CO., LTD. | Health Technology |
Aziende private | 6 |
---|---|
Mitobridge, Inc.
![]() Mitobridge, Inc. BiotechnologyHealth Technology Mitobridge, Inc. operates as a biopharmaceutical company. It focuses on the development and discovery of products for mitochondrial function. The firm also offers treatments for genetic, metabolic, and neurodegenerative disorders as well as diseases and conditions of aging. The company was founded by Kazumi Shiosaki, Andrew Dillin, Ronald M. Evans, Johan Auwerx and Robert H. Horvitz in October 2011 and is headquartered in Cambridge, MA. | Health Technology |
Potenza Therapeutics, Inc.
![]() Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Health Technology |
Astellas Venture Management LLC
![]() Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | Finance |
Ono Venture Investment, Inc.
![]() Ono Venture Investment, Inc. Investment ManagersFinance Ono Venture Investment Inc (Ono Venture Investment) is a venture capital arm of Ono Pharmaceutical Co Ltd. founded in 2020. The firm is headquartered in San Francisco, California. | Finance |
Astellas Pharma US, Inc.
![]() Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Health Technology |
Ono Pharma USA, Inc.
![]() Ono Pharma USA, Inc. Internet Software/ServicesTechnology Services Part of Ono Pharmaceutical Co., Ltd., Ono Pharma USA, Inc. operates as a pharmaceutical platform. The company is based in Cambridge, MA. The company was founded in 1998. The CEO is Kunihiko Ito. | Technology Services |
- Borsa valori
- Insiders
- Shunichiro Matsumoto
- Esperienza